Antagonism by propranolol of the inhibitory effect of phenoxybenzamine on noradrenaline uptake in vivo.
D000818:Animals; D001665:Binding Sites; D003042:Cocaine / Q000494:pharmacology; D003080:Cold Temperature; D003891:Desipramine / Q000494:pharmacology; D004336:Drug Antagonism; D005260:Female; D006145:Guanethidine / Q000494:pharmacology; D007279:Injections, Subcutaneous; D008297:Male; D051379:Mice; D009206:Myocardium / Q000378:metabolism*; D009638:Norepinephrine / Q000378:metabolism*; D010643:Phenoxybenzamine / Q000494:pharmacology*; D010646:Phentolamine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology*; D051381:Rats; D013997:Time Factors; D014316:Tritium
D010643:Phenoxybenzamine; D014316:Tritium; D011433:Propranolol; D003042:Cocaine; D003891:Desipramine; D009638:Norepinephrine; D010646:Phentolamine; D006145:Guanethidine